Surgery Partners, Inc.SGRYNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+27.4%
5Y CAGR+27.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+27.4%/yr
vs +33.5%/yr prior
5Y CAGR
+27.9%/yr
Consistent
Acceleration
-6.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$950.70M+89.6%
2024$501.40M+12.4%
2023$446.10M-3.0%
2022$460.00M+14.7%
2021$401.00M+44.3%
2020$277.80M-10.4%
2019$310.00M+114.3%
2018$144.68M-42.6%
2017$251.88M+2.7%
2016$245.23M-